274 related articles for article (PubMed ID: 19107959)
21. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
Graham BS; Davis TH; Tang YW; Gruber WC
Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
[TBL] [Abstract][Full Text] [Related]
22. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
23. Host transcription profiles upon primary respiratory syncytial virus infection.
Janssen R; Pennings J; Hodemaekers H; Buisman A; van Oosten M; de Rond L; Oztürk K; Dormans J; Kimman T; Hoebee B
J Virol; 2007 Jun; 81(11):5958-67. PubMed ID: 17376894
[TBL] [Abstract][Full Text] [Related]
24. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
[TBL] [Abstract][Full Text] [Related]
25. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
Li L; Yu CH; Ying HZ; Yu JM
J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
[TBL] [Abstract][Full Text] [Related]
26. [Primary respiratory syncytial virus infection in mice].
Zou Y; Huang H; Xu J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):484-6. PubMed ID: 11718040
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of respiratory syncytial virus by intravenous gamma-globulin].
Li YH; Zhang GC; Xu DL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):640-2. PubMed ID: 16143076
[TBL] [Abstract][Full Text] [Related]
28. Effects of norakin on respiratory syncytial virus in tissue culture and in mice.
Mentel R; Schroeder C; Döhner L
Acta Virol; 1989 Mar; 33(2):162-6. PubMed ID: 2569812
[TBL] [Abstract][Full Text] [Related]
29. Respiratory syncytial virus infection in a murine model of cystic fibrosis.
Colasurdo GN; Fullmer JJ; Elidemir O; Atkins C; Khan AM; Stark JM
J Med Virol; 2006 May; 78(5):651-8. PubMed ID: 16555274
[TBL] [Abstract][Full Text] [Related]
30. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro.
Franke-Ullmann G; Pförtner C; Walter P; Steinmüller C; Lohmann-Matthes ML; Kobzik L; Freihorst J
J Immunol; 1995 Jan; 154(1):268-80. PubMed ID: 7995946
[TBL] [Abstract][Full Text] [Related]
31. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination.
Helson R; Olszewska W; Singh M; Megede JZ; Melero JA; O'Hagan D; Openshaw PJ
Vaccine; 2008 Feb; 26(6):753-61. PubMed ID: 18191308
[TBL] [Abstract][Full Text] [Related]
32. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
33. Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection.
Fischer JE; Johnson JE; Johnson TR; Graham BS
J Infect Dis; 2000 Oct; 182(4):1029-38. PubMed ID: 10979896
[TBL] [Abstract][Full Text] [Related]
34. Lovastatin treatment mitigates the pro-inflammatory cytokine response in respiratory syncytial virus infected macrophage cells.
Ravi LI; Li L; Wong PS; Sutejo R; Tan BH; Sugrue RJ
Antiviral Res; 2013 May; 98(2):332-43. PubMed ID: 23523944
[TBL] [Abstract][Full Text] [Related]
35. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone.
Bonville CA; Mehta PA; Krilov LR; Rosenberg HF; Domachowske JB
Cell Immunol; 2001 Nov; 213(2):134-40. PubMed ID: 11831875
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
Welliver TP; Reed JL; Welliver RC
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
[TBL] [Abstract][Full Text] [Related]
37. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
[TBL] [Abstract][Full Text] [Related]
38. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
[TBL] [Abstract][Full Text] [Related]
39. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.
Chang YC; Chow YH; Sun HL; Liu YF; Lee YT; Lue KH; Ko JL
Antiviral Res; 2014 Oct; 110():124-31. PubMed ID: 25131377
[TBL] [Abstract][Full Text] [Related]
40. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
Dakhama A; Lee YM; Ohnishi H; Jing X; Balhorn A; Takeda K; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):138-145.e5. PubMed ID: 19056111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]